Yelena Y. Janjigian, Markus H. Moehler, Jaffer A. Ajani, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M. Cleary, Elena Elimova, Ricardo Elias Bruges, Michalis Karamouzis, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshu Liu, Mustapha Tehfe, Stephen McCraith, Nan Hu, Jennifer Zhang, Kohei Shitara. "Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up results from CheckMate 649.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.398